Peihua Gu
Overview
Explore the profile of Peihua Gu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
601
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Zhou J, Zhang H, Gu P, Margolick J, Yin D, Zhang Y
Breast Cancer Res Treat
. 2008 May;
115(2):269-77.
PMID: 18506619
Increasing evidence suggests that breast cancer is caused by cancer stem cells and the cure of breast cancer requires eradication of breast cancer stem cells. In this study, we established...
12.
Zhou J, Zhang H, Gu P, Bai J, Margolick J, Zhang Y
Breast Cancer Res Treat
. 2007 Oct;
111(3):419-27.
PMID: 17965935
Accumulating evidence indicates that breast cancer is caused by cancer stem cells and cure of breast cancer requires eradication of breast cancer stem cells. Previous studies with leukemia stem cells...
13.
Zhou J, Wulfkuhle J, Zhang H, Gu P, Yang Y, Deng J, et al.
Proc Natl Acad Sci U S A
. 2007 Oct;
104(41):16158-63.
PMID: 17911267
Side-population (SP) cells within cancers and cell lines are rare cell populations known to enrich cancer stem-like cells. In this study, we characterized SP cells from the human breast cancer...
14.
Byrne S, Gu P, Zhou J, Denkin S, Chong C, Sullivan D, et al.
Antimicrob Agents Chemother
. 2007 Sep;
51(12):4495-7.
PMID: 17876006
Diethyldithiocarbamate (DETC) and pyrrolidine dithiocarbamate (PDTC) were highly active against tubercle bacilli, with MICs of 8 microg/ml and 0.13 microg/ml, respectively. DETC and PDTC were active against old cultures, enhanced...
15.
Byrne S, Denkin S, Gu P, Nuermberger E, Zhang Y
J Med Microbiol
. 2007 Jul;
56(Pt 8):1047-1051.
PMID: 17644711
There is an urgent need for the development of new drugs that are active against drug-resistant Mycobacterium tuberculosis strains and can shorten tuberculosis (TB) therapy. It has previously been reported...